Jasper Therapeutics Inc. Company Profile
NASDAQ: JSPRHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
At close: Oct 8, 4:00 PM ET · Delayed 15 min
Jasper Therapeutics at a glance
Jasper Therapeutics Inc. (NASDAQ: JSPR) is a Biotechnology: Biological Products (No Diagnostic Substances) company in the Health Care sector headquartered in Redwood City, CA. The company's shares have traded publicly since 2020. At a market capitalization of $19.0 million, it is considered a small-cap company.
Its SEC Central Index Key (CIK) is 0001788028, which identifies the company's filings on EDGAR.
Summary generated from market data by MetaCap's automated system. Methodology
What does Jasper Therapeutics do?
Jasper Therapeutics, Inc., a clinical stage biotechnology company, focuses on the design and development of therapies to treat immune-mediated diseases. It is advancing a pipeline of medicines, including KP-104, a dual-complement inhibitor that has demonstrated positive outcomes in paroxysmal nocturnal hemoglobinuria (PNH) and is under evaluation in other unmet need nephrology disorders; Briquilimab is an anti-KIT antibody, which has demonstrated clinical results as a conditioning agent for stem cell transplant and mast cell mediated diseases, such as chronic urticarias and allergic asthma; and KP-701, a novel, dual-acting anti-CD79BxCD32B monoclonal antibody (mAb) for autoantibody-mediated disorders. The company is based in Redwood City, California.
Business description based on the company's public filings.
Company information
- Legal name
- Jasper Therapeutics Inc.
- Ticker
- NASDAQ: JSPR
- Sector
- Health Care
- Industry
- Biotechnology: Biological Products (No Diagnostic Substances)
- Headquarters
- 2200 Bridge Pkwy, Redwood City, CA, United States
- Phone
- 650-549-1400
- Website
- jaspertx.com
- IPO year
- 2020
- Market cap
- $18.96M
- SEC CIK
- 0001788028
Companies similar to Jasper Therapeutics
| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| ESLAEstrella Immunopharma Inc. | 0.4175 | -0.43% | $18.16M | vs JSPR |
| DYAIDyadic International Inc. | 0.4444 | -2.65% | $17.80M | vs JSPR |
| SCLXScilex Holding Company | 2.96 | -15.19% | $20.82M | vs JSPR |
| BCDABioCardia Inc. | 1.06 | -2.75% | $16.05M | vs JSPR |
| TCRXTScan Therapeutics Inc. | 0.2282 | -17.59% | $15.47M | vs JSPR |
| INABIN8bio Inc. | 1.38 | -1.43% | $13.60M | vs JSPR |
| ATYRaTyr Pharma Inc. | 0.2553 | -8.26% | $25.04M | vs JSPR |
| PLURPluri Inc. | 1.00 | -3.85% | $12.61M | vs JSPR |